News
United Therapeutics Corporation stock was down substantially yesterday as rival Insmed's PAH data blew the market away. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback